KLHL7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.73339995082722E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.199999999981E-06 |
Normal-vs-Stage2 |
1.568390E-02 |
Normal-vs-Stage3 |
1.505790E-02 |
Normal-vs-Stage4 |
1.684410E-01 |
Stage1-vs-Stage2 |
8.129000E-01 |
Stage1-vs-Stage3 |
8.838200E-01 |
Stage1-vs-Stage4 |
5.545400E-01 |
Stage2-vs-Stage3 |
7.477400E-01 |
Stage2-vs-Stage4 |
4.523000E-01 |
Stage3-vs-Stage4 |
6.151000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
6.86579999520376E-08 |
Normal-vs-AfricanAmerican |
6.163600E-04 |
Normal-vs-Asian |
8.143800E-02 |
Caucasian-vs-AfricanAmerican |
9.041200E-01 |
Caucasian-vs-Asian |
1.973390E-01 |
AfricanAmerican-vs-Asian |
2.732200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.42289999952128E-07 |
Normal-vs-Female |
1.77320000016579E-07 |
Male-vs-Female |
9.309600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
2.025600E-02 |
Normal-vs-Extreme_Weight |
1.202860E-04 |
Normal-vs-Obese |
7.83380000000111E-05 |
Normal-vs-Extreme_Obese |
1.355440E-01 |
Normal_Weight-vs-Extreme_Weight |
3.410400E-01 |
Normal_Weight-vs-Obese |
2.566600E-01 |
Normal_Weight-vs-Extreme_Obese |
6.194800E-01 |
Extreme_Weight-vs-Obese |
8.804000E-01 |
Extreme_Weight-vs-Extreme_Obese |
9.430600E-01 |
Obese-vs-Extreme_Obese |
8.728600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.951910E-04 |
Normal-vs-Age(41-60Yrs) |
9.45699962784374E-10 |
Normal-vs-Age(61-80Yrs) |
5.199300E-04 |
Normal-vs-Age(81-100Yrs) |
3.259600E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.309400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.957810E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.003400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.018700E-03 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.658400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.392200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
2.29405383578296E-12 |
Normal-VS-Type2 PRCC |
4.957200E-01 |
Normal-VS-KIRP CIMP |
4.379900E-03 |
Normal-VS-Unclassified PRCC |
4.744500E-03 |
Type1 PRCC-VS-Type2 PRCC |
6.76330000004555E-07 |
Type1 PRCC-VS-KIRP CIMP |
5.651400E-01 |
Type1 PRCC-VS-Unclassified PRCC |
1.808780E-01 |
Type2 PRCC-VS-KIRP CIMP |
7.821100E-03 |
Type2 PRCC-VS-Unclassified PRCC |
3.026400E-02 |
KIRP CIMP-VS-Unclassified PRCC |
2.159000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
5.469800E-02 |
Normal-vs-N1 |
1.353550E-02 |
Normal-vs-N2 |
2.133900E-02 |
N0-vs-N1 |
2.129600E-01 |
N0-vs-N2 |
5.738000E-01 |
N1-vs-N2 |
9.529200E-01 |
|
|